U.S. Insurers Could Spend Millions for Ivermectin Rx for COVID-19

THURSDAY, Jan. 20, 2022 (HealthDay News) -- Insurers could prevent substantial waste by restricting prescription coverage for inappropriate use of ivermectin for COVID-19, according to a research letter published online Jan. 13 in the Journal of the American Medical Association.
Kao-Ping Chua, M.D., Ph.D., from University of Michigan Medical School in Ann Arbor, and colleagues used national claims data to identify 5 million patients with private insurance and 1.2 million with Medicare Advantage (Dec. 1, 2020, through March 31, 2021).
The researchers identified 5,591 ivermectin prescriptions, of which 84.1 percent were for privately insured patients (mean age, 51.8 years). Mean out-of-pocket spending was $22.48 for privately insured patients and $13.78 for Medicare Advantage patients, with mean insurer reimbursement of $35.75 and $39.13, respectively. Aggregate total spending was $273,681 for privately insured patients and $47,142.81 for Medicare Advantage patients. However, in the week of Aug. 13, 2021, private insurance paid an estimated $1.6 million and Medicare plans paid $924,720 for ivermectin prescriptions for COVID-19 (extrapolated to $129,673,240.30 annually).
"Findings suggest that insurers heavily subsidized the costs of ivermectin prescriptions for COVID-19, even though economic theory holds that insurers should not cover ineffective care," the authors write.
Related Posts
AHA News: Lifelong Runner and Newlywed Gets Pacemaker to Power Her Heart
WEDNESDAY, Feb. 8, 2023 (American Heart Association News) -- After their Hawaii...
Decision Support System Cuts Pneumonia Deaths in Community Hospitals
WEDNESDAY, March 23, 2022 (HealthDay News) -- A real-time electronic decision...
Many Strains of a Dangerous Foodborne Bacteria Are Now Antibiotic-Resistant
WEDNESDAY, Sept. 6, 2023 (HealthDay News) -- New research on a leading cause of...
Una nueva comprensión sobre los genes que provocan la epilepsia podría ayudar con el tratamiento
LUNES, 6 de septiembre de 2021 (HealthDay News) -- Unos investigadores daneses...
